论文部分内容阅读
Parkinsons disease(PD)is a neurodegenerative disease,which is mainly occurred in elderly person.
The protective effect of NMDA receptor inhibitors on nigral iron accumulation in 6-OHDA-induced Park
【摘 要】
：
Parkinsons disease(PD)is a neurodegenerative disease,which is mainly occurred in elderly person.
【机 构】
：
Department of Physiology,Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurol
【出 处】
：
The 6th FAONS Congress and 11th Biennial Conference of CNS(第
【发表日期】
：
2015年3期
其他文献
Parkinsons disease(PD)is a progressive neurodegenerative movement disorder that is caused predominantly by the degeneration of the nigrostriatal dopaminergic pathway.
Sodium butyrate ameliorates memory deficit,increases neurogenesis and reduces inflammation in presen
会议
Objective Alzheimer disease is characterized by progressive memory loss and damaging of cognitive functions.
Etidronate and trisphosphonates are new potential candidates for neuroprotective drugs for Alzheimer
Objective Bisphosphonates(BP)is a category of drugs that are used to treat various bone diseases,such as osteoporosis,Pagets disease,bone malignancy and other skeletal complications involving excessiv
Alteration of dopamine related oxidase in stomach and duodenum of 6-hydroxydopamine-induced Parkinso
Parkinsons disease(PD)is characterized by degeneration of dopaminergic neurons in the substantia nigra.Besides,the changes of dopaminergic neurons have been reported in enteric nervous system of PD pa
Background: Mild cognitive impairment(MCI)is an intermediate period between normal ageing and Alzheimer disease.
Protection effect of piperine and piperlonguminine from Piper longum L.alkaloids against rotenone-in
Objective Parkinson disease(PD)is a chronic progressive disease which could involve multiple systems at its early stage while the central nervous system was finally injured at its later stage and mani
Objective Alzheimers disease(AD)is the most common form of dementia in elderly people.
Objective Müller cell gliosis is a common response in virtually all forms of retinal diseases including glaucoma.
We have demonstrated that bradykinin(BK)could increase the permeability of blood-tumor barrier(BTB)via down-regulating the protein expressions of tight junction(TJ)associated protein claudin-5 and occ